Christopher Kalberg - Concepedia

Concepedia

Author

Christopher Kalberg

Research Triangle Park Foundation

Also Known As

Brooks, Jean, Christopher J. Kalberg, Christopher Kalberg

22

Publications

1.3K

Citations

15

H-Index

27

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)GlaxoSmithKline (Netherlands)The University of Texas Health Science Center at San Antonio University of North Carolina at Chapel Hill

CK

About

Christopher Kalberg is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and asthma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	737
2	Allergy	5	5	402
3	Health Sciences	1	1	59
4	Allergy Medicine	1	1	20
5	Biochemistry	1	1	12

Christopher Kalberg

×

15

Publications

1.3K

Citations

14

H-Index

	Year	Citations
Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations Gary T. Ferguson, Antonio Anzueto, Richard Fei, Respiratory Medicine	2008	245
Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes Antonio Anzueto, Gary T. Ferguson, Greg Feldman, COPD Journal of Chronic Obstructive Pulmonary Disease	2009	187
The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma John J. Condemi, Stanley Goldstein, Christopher Kalberg, Annals of Allergy Asthma & Immunology AsthmaAllergyPharmacologyFluticasone PropionatePharmacotherapy	1999	152
Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma William W. Busse, Harold S. Nelson, James Wolfe, Journal of Allergy and Clinical Immunology AsthmaAllergyOral ZafirlukastPulmonary PharmacologyInhaled Salmeterol	1999	144
Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations Jonathan Matz, Amanda Emmett, Kathleen Rickard, Journal of Allergy and Clinical Immunology AsthmaClinical AllergyMedicinePharmacotherapyAllergic Rhinitis	2001	129
Effect of Long-term Salmeterol Therapy Compared With As-Needed Albuterol Use on Airway Hyperresponsiveness Richard R. Rosenthal, William W. Busse, James P. Kemp, CHEST Journal	1999	67
A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD James F. Donohue, Antonio Anzueto, Jean Brooks, Respiratory Medicine Novel Lama Gsk573719Advanced Lung DiseasePulmonary MedicineDouble-blind Dose-ranging StudyMedicine	2012	65
Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma John M. Weiler, Robert A. Nathan, Ned T. Rupp, Annals of Allergy Asthma & Immunology AsthmaMedicineExerciseExercise PhysiologyPulmonary Pharmacology	2005	59
A Short-Term Comparison of Fluticasone Propionate/Salmeterol with Ipratropium Bromide/Albuterol for the Treatment of COPD James F. Donohue, Christopher Kalberg, Amanda Emmett, Treatments in Respiratory Medicine Fluticasone Propionate/salmeterolAdvanced Lung DiseaseMedicineShort-term ComparisonPulmonary Pharmacology	2004	54
Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: Response by beta-agonist reversibility Eugene R. Bleecker, Amanda Emmett, Glenn Crater, Pulmonary Pharmacology & Therapeutics AllergyAdvanced Lung DiseaseBeta-agonist ReversibilityMedicinePulmonary Physiology	2008	54

Page 1